J. Charles

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

Sandra P. D’Angelo, James Larkin, Jeffrey A. Sosman et al. · Journal of Clinical Oncology · 2017 · 643 citations · Full text

Medicine, Immunology, Oncology +17

Survival Outcomes in Patients With Previously Untreated <i>BRAF</i> Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

Paolo A. Ascierto, Georgina V. Long, Caroline Robert et al. · JAMA Oncology · 2018 · 345 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · Journal of Clinical Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL

Caroline Aspord, M.‐T. Leccia, J. Charles et al. · Cancer Immunology Research · 2013 · 188 citations · Full text

Medicine, Immunology, Oncology +13